Full talk · edited transcript

Not by Diagnostics Alone: ML for Designing Therapeutic Proteins

Daria Tsyba25 May 2024

Daria Tsyba, Research Scientist, Department of Early Drug Development, Geropharm.

A talk about how ML is applied in the early stages of development of protein-based drugs, what form of protein can be fed into the model, and why the data for each of these formats are "horrible." At the end, on a practical case, Random Forest and CatBoost are compared for predicting post-translational modification (deamidation) in candidate molecules.

Continue reading — it's free

Google or a one-time email code. No password.